Literature DB >> 22142409

Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering.

Joaquin Seras-Franzoso1, César Díez-Gil, Esther Vazquez, Elena García-Fruitós, Rafael Cubarsi, Imma Ratera, Jaume Veciana, Antonio Villaverde.   

Abstract

BACKGROUND: Bacterial inclusion bodies (IBs), mechanically stable, submicron protein particles of 50-500 nm dramatically favor mammalian cell spread when used for substrate surface decoration. The mechanisms supporting fast colonization of IB-modified surfaces have not yet been identified.
RESULTS: This study provides evidence of mechanotransduction-mediated stimulation of mammalian cell proliferation on IB-decorated surfaces, as observed by the enhanced phosphorylation of the signal-regulated protein kinase and by the dramatic emission of filopodia in the presence of IBs. Interestingly, the results also show that IBs are highly bioadhesive materials, and that mammalian cell expansion on IBs is synergistically supported by both enhanced adhesion and mechanical stimulation of cell division. DISCUSSION: The extent in which these events influence cell growth depends on the particular cell line response but it is also determined by the genetic background of the IB-producing bacteria, thus opening exciting possibilities for the fine tailoring of protein nanoparticle features that are relevant in tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142409     DOI: 10.2217/nnm.11.83

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  8 in total

1.  Purification of Inclusion Bodies Produced in Bacteria and Yeast.

Authors:  Joaquin Seras-Franzoso; Olivia Cano-Garrido; Spela Peternel; Anna Arís; Elena Garcia-Fruitós
Journal:  Methods Mol Biol       Date:  2022

2.  Methods for Processing Protein Aggregates into Surfaces.

Authors:  Marc Martínez-Miguel; Witold Tatkiewicz; Mariana Köber; Nora Ventosa; Jaume Veciana; Judith Guasch; Imma Ratera
Journal:  Methods Mol Biol       Date:  2022

3.  Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells.

Authors:  Irene Barguilla; Ugutz Unzueta; Jose Vicente Carratalá; Olivia Cano-Garrido; Antonio Villaverde; Alba Hernández; Neus Ferrer-Miralles
Journal:  Front Bioeng Biotechnol       Date:  2022-04-29

4.  Packaging protein drugs as bacterial inclusion bodies for therapeutic applications.

Authors:  Antonio Villaverde; Elena García-Fruitós; Ursula Rinas; Joaquin Seras-Franzoso; Ana Kosoy; José Luis Corchero; Esther Vazquez
Journal:  Microb Cell Fact       Date:  2012-06-11       Impact factor: 5.328

5.  Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.

Authors:  María Virtudes Céspedes; Yolanda Fernández; Ugutz Unzueta; Rosa Mendoza; Joaquin Seras-Franzoso; Alejando Sánchez-Chardi; Patricia Álamo; Verónica Toledo-Rubio; Neus Ferrer-Miralles; Esther Vázquez; Simó Schwartz; Ibane Abasolo; José Luis Corchero; Ramon Mangues; Antonio Villaverde
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

6.  Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl.

Authors:  Anne Stamm; Sarah Strauß; Peter Vogt; Thomas Scheper; Iliyana Pepelanova
Journal:  Microb Cell Fact       Date:  2018-04-07       Impact factor: 5.328

Review 7.  Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications.

Authors:  Arshpreet Bhatwa; Weijun Wang; Yousef I Hassan; Nadine Abraham; Xiu-Zhen Li; Ting Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-02-10

8.  Intracellular CXCR4⁺ cell targeting with T22-empowered protein-only nanoparticles.

Authors:  Ugutz Unzueta; María Virtudes Céspedes; Neus Ferrer-Miralles; Isolda Casanova; Juan Cedano; José Luis Corchero; Joan Domingo-Espín; Antonio Villaverde; Ramón Mangues; Esther Vázquez
Journal:  Int J Nanomedicine       Date:  2012-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.